Licence details
Miruku Australia Pty Ltd
Brassica napus L./Canola
Dairy protein production; Selectable marker – herbicide tolerance
This licence allows Miruku Australia Pty Ltd to grow field trials of canola genetically modified for dairy protein production.
The GM canola may be grown from issue of the licence until December 2029.
The GM canola may be grown on an area of up to 1 hectare in 2025 and increasing to a maximum of 20 sites of up to 5 hectares each in 2029. The maximum total planting area is 206 hectares over the 5 years of the trial. The field sites may be in New South Wales, Victoria, Western Australia and South Australia.
The aim of the trial is to assess how the GM canola performs under field conditions.
The GM canola grown in the field trial will not be used in commercial human food or animal feed.
Miruku Australia Pty Ltd must comply with a range of licence conditions that restrict when and where the trial can take place, limit the size of the trial, and prevent the GM canola from spreading outside the trial. For example, there are conditions to contain the GM canola within the trial site, to securely transport and store the GM canola, and to destroy the GM canola at the end of the trial.
The risk analysis for this application was carried out in accordance with the Regulator’s Risk Analysis Framework.
You can find more information about GM plants authorised for release into the environment on our website.
Documents
Outlines the Regulator’s decision to issue a licence following the assessment of this application.
FAQs on the licence application and the Regulator’s decision to issue a licence for this application.
A summary of the Risk Assessment and Risk Management Plan prepared as part of the assessment of this application. It provides a brief description of the licence application, the risk assessment and risk management plan.
The final risk assessment and management plan prepared to support the Regulator's decision. It describes the GMO(s) and proposed work with the GMO(s) and provides an assessment of potential risks posed by the GMO(s). It also includes a summary of submissions received during the public consultation process.
Sets out the licence conditions imposed by the Regulator, including the licence holder’s general and specific obligations and reporting requirements.